Biogen’s stock blasts off after surprise reversal on Alzheimer’s drug, earnings beat
October 22, 2019 at 11:08 AM EDT
Shares of Biogen Inc. blasted off Tuesday, after the biotechnology company said its Alzheimer’s treatment is ready to start the regulatory approval process, and following third-quarter earnings that rose well-above expectations.